Furthermore, coexpansion of Tregs and cDC2‐like mregDCs results in tumour immune tolerance, while therapeutic depletion of Tregs effectively augments cDC2 maturation and reverses the phenotypic dysfunction, thereby facilitating the production of antitumour CD4+ T cells.51 This evidence concerns the gene CD4 and neoplasm.